Merck Millipore (U.S.), Sigma-Aldrich Corporation (U.S), PerkinElmer, Inc. (U.S.), Roche Applied Science (U.S), ProteinSimple, Inc. (U.S.), LI-COR Biosciences (U.S.), and Advansta, Inc. (U.S.)
(PRWEB) October 12, 2014
According to a new market research report, “Western Blotting Market by Product (Instruments (Manual/Semi-automated/Automated), Consumables (Kits/Reagents/Membrane), by Application (Disease Diagnosis/Agriculture/Biomedical Research) - End-User Analysis & Global Forecast to 2018” analyses and studies the major market drivers, threats, opportunities, and challenges.
Browse 63 market data tables, 24 figures spread through 201 pages and in-depth TOC on “Western Blotting Market”
Early buyers will receive 10% customization on this report.
This report studies the global western blotting marketover the forecast period of 2013 to 2018.This market was valued at $296.0 millions in 2013 and is poised to grow at a CAGR of 4.8% from 2013 to 2018, to reach $374.2 million by 2018.
Ask for PDf Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=235810711
The global western blotting market is segmented on the basis of products, applications, end users, and geographies. Based on products, the western blotting market comprises of instruments and consumables. The instruments are further segmented into manual, semi-automated, and automated.
The consumables are divided into kits, reagents, and others (western blotting membranes, blotting papers, and molecular markers). Reagents are further categorized into chromogenic reagents, chemiluminescent reagents, fluorescent reagents, chemifluorescent reagents, and radioisotopic reagents. On the basis of applications, the western blotting market is segmented into disease diagnosis, agriculture, biomedical and biochemical research, and others (QC test in biopharmaceutical industry and biologics).
The market by end users includes pharmaceuticals and biotechnology industries, research institutes, and diagnostic laboratories. The global western blotting market is witnessing a moderate growth and will continue to do so over the next five years. Factors such as the global increase in the life sciences R&D spending, development of automated western blotting systems, and rising prevalence of HIV contribute to the growth of the western blotting market. In the forecast period, the Asian region is projected to grow at the highest CAGR, with the growth in this region centered at India and China. Furthermore, countries such as Brazil, Australia, and South Africa also possess a reasonable projected growth.
Speak to Analyst for More Inquiry @ http://www.marketsandmarkets.com/speaktoanalyst.asp?id=235810711
Based on geography, the market is divided into North America, Europe, Asia, and the Rest of the World (RoW). North America is the largest market for western blotting, followed by Europe and Asia. However, the Asian market is slated to grow at the highest CAGR inthe coming five years.
Over the years, the demand for western blotting instruments and consumables is likely to increase owing to a number of factors such as automation in western blotting instruments and rising incidences of Lyme disease and HIV infection. However, the high costs of primary antibodies and the extreme care required to achieve accuracy are the major factors hindering the growth of this market.
Key players in the global western blotting market include Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.),Sigma-Aldrich Corporation (U.S.), Merck Millipore (U.S.), GE Healthcare (U.K.), PerkinElmer, Inc. (U.S.), Roche Applied Science(U.S.), ProteinSimple, Inc. (U.S.), LI-COR Biosciences (U.S.), and Advansta, Inc. (U.S.).
Browse Related Reports:
Epigenetics Market by Product (Modifying Enzymes, DNA Polymerase, Acetylase, Methyltransferase, Instruments & Consumables, Kit, Bisulphite Conversion Kit, Reagents), Research Area (Developmental Biology, Oncology) & by End User - Global Forecast to 2019
Patient Engagement Solutions Market by Component (Hardware, Software & Services), Delivery Mode (On-premise, Web, & Cloud) & by End-user (Payer, Provider, Patients,& Others) - Trends & Global Forecasts to 2019
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza,
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog@ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn@ http://www.linkedin.com/company/marketsandmarkets